GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Swedencare AB (OTCPK:SWDCF) » Definitions » Debt-to-EBITDA

Swedencare AB (Swedencare AB) Debt-to-EBITDA : 3.06 (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Swedencare AB Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Swedencare AB's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was $3.9 Mil. Swedencare AB's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was $154.0 Mil. Swedencare AB's annualized EBITDA for the quarter that ended in Mar. 2024 was $51.7 Mil. Swedencare AB's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2024 was 3.05.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Swedencare AB's Debt-to-EBITDA or its related term are showing as below:

SWDCF' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.09   Med: 2.49   Max: 5.2
Current: 3.2

During the past 10 years, the highest Debt-to-EBITDA Ratio of Swedencare AB was 5.20. The lowest was 0.09. And the median was 2.49.

SWDCF's Debt-to-EBITDA is ranked worse than
68.53% of 661 companies
in the Drug Manufacturers industry
Industry Median: 1.61 vs SWDCF: 3.20

Swedencare AB Debt-to-EBITDA Historical Data

The historical data trend for Swedencare AB's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Swedencare AB Debt-to-EBITDA Chart

Swedencare AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.09 3.26 5.20 4.89 3.43

Swedencare AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.51 4.29 3.24 3.08 3.06

Competitive Comparison of Swedencare AB's Debt-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Swedencare AB's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Swedencare AB's Debt-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Swedencare AB's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Swedencare AB's Debt-to-EBITDA falls into.



Swedencare AB Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Swedencare AB's Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(3.685 + 158.468) / 47.214
=3.43

Swedencare AB's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2024 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(3.861 + 153.996) / 51.676
=3.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Mar. 2024) EBITDA data.


Swedencare AB  (OTCPK:SWDCF) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Swedencare AB Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Swedencare AB's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Swedencare AB (Swedencare AB) Business Description

Traded in Other Exchanges
Address
Per Albin Hanssons Vag 41, Medeon Science Park, Malmo, SWE, 205 12
Swedencare AB is specialized in pet healthcare and produces partly in own factories, markets and sells premium products on the global market. The company has a wide range of brands and products within most therapy areas, which includes Animal Pharmaceuticals, nutravet, NutriScience, PetMD, Stratford, VetWELL as well as ProDen PlaqueOff for oral health to dogs and cats. The company's products are sold in approximately fifty markets.

Swedencare AB (Swedencare AB) Headlines

No Headlines